
Results
2
2 companies
argenx
Market Cap: €44.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€718.60
7D
-1.9%
1Y
13.8%
Campine
Market Cap: €318.0m
Engages in the circular metals and specialty chemicals businesses in Belgium and internationally.
CAMB
€212.00
7D
-5.4%
1Y
65.6%